Home
Products
Gene
mRNA Products
mRNAs for Allergy Tolerization
mRNAs for Allergy Tolerization

mRNAs for Allergy Tolerization

mRNA vaccines open the field for a safety-optimized prophylactic vaccination in opposition to allergic diseases. Conventional as well as self-replicating mRNA vaccines have proven their capability to prevent the induction of an allergic phenotype in terms of allergen-specific IgE, allergy-related cytokine profiles, eosinophilic lung infiltration, and airway hyperreactivity. Along with wide range of services in the field of theraupetic development, Seattle Genova also offer services for mRNA merchandise used against allergies.  

Compare
Catalog Number
Gene Name
Product Name
More
Aca f 1
Aca f 1 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0001
Aca f 1 Circular RNA
In Vitro Transcribed mRNA template encoding Aca f 1 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0001-LNP
Aca f 1 Circular RNA-LNP
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Aca f 2
Aca f 2 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0002
Aca f 2 Circular RNA
In Vitro Transcribed mRNA template encoding Aca f 2 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0002-LNP
Aca f 2 Circular RNA-LNP
ALG-ORNA-0002 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Aca s 13
Aca s 13 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0003
Aca s 13 Circular RNA
In Vitro Transcribed mRNA template encoding Aca s 13 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0003-LNP
Aca s 13 Circular RNA-LNP
ALG-ORNA-0003 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Act c 1
Act c 1 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0004
Act c 1 Circular RNA
In Vitro Transcribed mRNA template encoding Act c 1 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0004-LNP
Act c 1 Circular RNA-LNP
ALG-ORNA-0004 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Act c 10
Act c 10 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0005
Act c 10 Circular RNA
In Vitro Transcribed mRNA template encoding Act c 10 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0005-LNP
Act c 10 Circular RNA-LNP
ALG-ORNA-0005 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Act c 5
Act c 5 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0006
Act c 5 Circular RNA
In Vitro Transcribed mRNA template encoding Act c 5 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0006-LNP
Act c 5 Circular RNA-LNP
ALG-ORNA-0006 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Act c 8
Act c 8 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0007
Act c 8 Circular RNA
In Vitro Transcribed mRNA template encoding Act c 8 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0007-LNP
Act c 8 Circular RNA-LNP
ALG-ORNA-0007 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Act d 1
Act d 1 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0008
Act d 1 Circular RNA
In Vitro Transcribed mRNA template encoding Act d 1 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0008-LNP
Act d 1 Circular RNA-LNP
ALG-ORNA-0008 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Act d 10
Act d 10 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0009
Act d 10 Circular RNA
In Vitro Transcribed mRNA template encoding Act d 10 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0009-LNP
Act d 10 Circular RNA-LNP
ALG-ORNA-0009 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Act d 11
Act d 11 Circular RNA
Expand
SKU
Product_name
Product Description
ALG-ORNA-0010
Act d 11 Circular RNA
In Vitro Transcribed mRNA template encoding Act d 11 was further circularized with Seattle Genova's Ostar technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
ALG-ORNA-0010-LNP
Act d 11 Circular RNA-LNP
ALG-ORNA-0010 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.499250s